Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Change in Accured Expenses (2017 - 2025)

Selectis Health's Change in Accured Expenses history spans 14 years, with the latest figure at -$748246.0 for Q3 2025.

  • For Q3 2025, Change in Accured Expenses fell 210.83% year-over-year to -$748246.0; the TTM value through Sep 2025 reached $720350.0, down 65.14%, while the annual FY2024 figure was $528834.0, 77.98% down from the prior year.
  • Change in Accured Expenses for Q3 2025 was -$748246.0 at Selectis Health, down from -$151200.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.9 million in Q4 2021 and bottomed at -$2.0 million in Q3 2022.
  • The 5-year median for Change in Accured Expenses is $238906.0 (2024), against an average of $211584.5.
  • The largest annual shift saw Change in Accured Expenses surged 1045.69% in 2021 before it crashed 972.0% in 2022.
  • A 5-year view of Change in Accured Expenses shows it stood at $1.9 million in 2021, then tumbled by 36.14% to $1.2 million in 2022, then skyrocketed by 37.07% to $1.6 million in 2023, then plummeted by 94.31% to $92753.0 in 2024, then tumbled by 906.71% to -$748246.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Change in Accured Expenses are -$748246.0 (Q3 2025), -$151200.0 (Q2 2025), and $1.5 million (Q1 2025).